South Australia research institute CMAX has announced success with a potential new treatment for retinitis pigmentosa (RP). RP is a...
Read moreDetailsResearchers at the National Institutes of Health (NIH) in the United States say they have developed eye drops that extend...
Read moreDetailsOutcomes from the bionic eye trial have demonstrated the device’s long-term durability and stability in the retina. The detailed outcomes...
Read moreDetails
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited